Abstract: To investigate the relationship between non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MetS) in patients with latent autoimmune diabetes in adults (LADA). A total of 223 hospitalized patients were recruited between January 2007 and June 2009 in Department of Endocrinology and Metabolism of the Sixth People's Hospital Affiliated to Shanghai Jiaotong University. Finally, 142 patients with complete clinical data and without history of drinking were included in this study. According to the Chinese Medical Association's Guidelines of NAFLD, based on the result of ultrasound, all subjects were divided into two groups including patients with LADA and NAFLD (=37) and patients with LADA but without NAFLD (=105). Clinical data including diabetes duration, history of smoking and medications, height, weight, blood pressure, blood lipids, blood glucose, C-peptide, and liver and kidney function were collected. The prevalence and components of MetS were compared between two groups. The association between MetS and NAFLD was also explored. After adjusting for age and sex, compared with the subjects without NAFLD, the subjects with NAFLD were older and had higher percentage of hypertension, and had higher body mass index[(26.5±3.7) kg/m(2) vs (21.9±3.1) kg/m(2)], waist-hip ratio(0.92±0.06 vs 0.86±0.07), low density lipoprotein cholesterol[(3.26±0.72) mmol/L vs (2.70±0.87) mmol/L], C-reactive protein, fasting C-peptide, 2 h postprandial C-peptide, systolic blood pressure, diastolic blood pressure, alanine aminotransferase and triglyceride (all <0.05). But they had lower high-density lipoprotein cholesterol[(1.17±0.43) mmol/L vs (1.35±0.40) mmol/L]and HbA1c[(8.83±2.14) % vs (10.02±2.79)%](both <0.05). In addition, after adjusting for age and sex, compared with the patients with LADA but without NAFLD, the prevalence of MetS in the patients with LADA and NAFLD was obviously higher (97.3% vs 47.6%, <0.001), and the proportion of the patients with four (32.4% vs 16.2%, <0.001) and five (43.2% vs 5.7%, <0.001) components of MetS in the patients with LADA and NAFLD was also significantly increased than that in the patients with LADA but without NAFLD. Binary regression analysis showed that NAFLD was an independent factor associated with MetS in the patients with LADA after correcting other confounding factors (<0.001). Compared with the patients with LADA but without NAFLD, the prevalence of MetS was obviously higher, and had more serious metabolic disorder in the patients with LADA and NAFLD. The presence of NAFLD was an independent factor associated with MetS in the patients with LADA.

[Clinical Features of Non-Alcoholic Fatty Liver Disease and Its Relationship with Serum C-peptide Levels in Patients with Latent Autoimmune Diabetes in Adults].

[The relationship between non-alcoholic fatty liver disease and metabolic syndrome in patients with latent autoimmune diabetes in adults].

Association of Nonalcoholic Fatty Liver Disease with Type 2 Diabetes: Clinical Features and Independent Risk Factors in Diabetic Fatty Liver Patients.

Glucagon is Associated with NAFLD Inflammatory Progression in Type 2 Diabetes, Not with NAFLD Fibrotic Progression.

Fatty Acid Profiles and Their Association With Autoimmunity, Insulin Sensitivity and β Cell Function in Latent Autoimmune Diabetes in Adults

Clinical clues for screening latent autoimmune diabetes from adults patients with type 2 diabetic mellitus

Utility of Fasting C-Peptide for the Diagnostic Differentiation of Patients with Type 1, Type 2 Diabetes, MODY, and LADA

Urinary C-Peptide Creatinine Ratio As a Non-Invasive Tool for Identifying Latent Autoimmune Diabetes in Adults (LADA)

C-Peptide: A Mediator of the Association Between Serum Uric Acid to Creatinine Ratio and Non-Alcoholic Fatty Liver Disease in a Chinese Population With Normal Serum Uric Acid Levels

[Cross-Sectional Study of the Relation Between Carboxypeptidase-H Antibody and Islet Beta Cell Function in Patients with Latent Autoimmune Diabetes in Adults].

Clinical manifestation and islet β-cell function of a subtype of latent autoimmune diabetes in adults (LADA): positive for T cell responses in phenotypic type 2 diabetes

Islet β-cell function in the patients with latent autoimmune diabetes of adults: a prospective study

222-LB: Islet Dysfunction and Progression of NAFLD in Diabetic Patients: Islet-Liver Cross Talk from Metal Study

Latent Autoimmune Diabetes in Adults with Low-Titer GAD Antibodies: Similar Disease Progression with Type 2 Diabetes

1793-LB: Subclinical Atherosclerosis in Latent Autoimmune Diabetes—Insights from a Multicenter Prospective Interventional Study

The Analysis of the Clinical Characteristics of the Secondary Diabetes of Alcoholic Chronic Pancreatitis

Clinical characteristics and diagnostic models of latent autoimmune diabetes in adults with newly diagnosed type 2 diabetes mellitus

Clinical features of the latent autoimmune diabetes in adults with albuminuria and its correlation with atherosclerosis

Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3).

Analysis on the Clinical Features of the LADA Patients

Serum proinsulin levels in LADA patients